🟢 Connect Biopharma is trading 14.98% up in pre-market alongside XBI’s 2.08% gain

Connect Biopharma is trading at $0.90, up 14.98%, with the move aligning with biotech-sector strength.

• No new company-specific announcement explaining the November 5 pre-market move was found; the company’s investor page lists prior clinical data and financial updates.
• Recent reporting described biotech gains alongside broad-market advances, with Amgen’s earnings among the industry’s positive news.
• XBI was up 2.08% pre-market; no trading-volume details were available.